“Sotiria” Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The 3rd Cardiology Department at Sotiria Chest Disease Hospital is conducting research in cardiovascular diseases, with a focus on improving care for patients at risk of serious heart and blood vessel complications. The trials explore both prevention strategies and better treatment options for common and high-risk cardiovascular conditions.
- Stroke prevention in atrial fibrillation occurring after stress, such as noncardiac surgery or acute medical illness
- Management of established cardiovascular disease and high cardiovascular risk
- Better control of hypertension to reduce major cardiovascular events
These studies are designed to evaluate whether new approaches can lower the risk of stroke, heart attack, vascular complications, and heart failure-related events, while also helping refine treatment decisions for patients with complex cardiovascular profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Alnylam Pharmaceuticals Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in “Sotiria” Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Patients with Perioperative Atrial Fibrillation Post-Noncardiac Surgery | Hamilton Health Sciences Corporation | Phase III | Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Apixaban | 1 | Unknown | 2024-01-29 | 2024-01-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.